Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/169355
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorGerboth, S.-
dc.contributor.authorFrittoli, E.-
dc.contributor.authorPalamidessi, A.-
dc.contributor.authorBaltanás, Fernando C.-
dc.contributor.authorSalek, M.-
dc.contributor.authorRappsilber, J.-
dc.contributor.authorGiuliani, C.-
dc.contributor.authorTroglio, F.-
dc.contributor.authorRolland, Y.-
dc.contributor.authorPruneri, G.-
dc.contributor.authorKreutmair, S.-
dc.contributor.authorPallavicini, I.-
dc.contributor.authorZobel, M.-
dc.contributor.authorCinquanta, M.-
dc.contributor.authorMinucci, S.-
dc.contributor.authorGómez, Carmela-
dc.contributor.authorIllert, A.L.-
dc.contributor.authorScita, G.-
dc.date.accessioned2018-09-03T11:47:16Z-
dc.date.available2018-09-03T11:47:16Z-
dc.date.issued2018-
dc.identifierdoi: 10.1038/leu.2017.267-
dc.identifiere-issn: 1476-5551-
dc.identifierissn: 0887-6924-
dc.identifier.citationLeukemia 32(3): 820-827 (2018)-
dc.identifier.urihttp://hdl.handle.net/10261/169355-
dc.description.abstractSon of Sevenless 1 (SOS1) is a dual guanine nucleotide exchange factor (GEF) that activates the small GTPases RAC and RAS. Although the molecular mechanisms of RAS GEF catalysis have been unveiled, how SOS1 acquires RAC GEF activity and what is the physio-pathological relevance of this activity is much less understood. Here we show that SOS1 is tyrosine phosphorylated on Y1196 by ABL. Phosphorylation of Y1196 controls SOS1 inter-molecular interaction, is required to promote the exchange of nucleotides on RAC in vitro and for platelet-derived growth factor (PDGF) activation of RAC- and RAC-dependent actin remodeling and cell migration. SOS1 is also phosphorylated on Y1196 by BCR-ABL in chronic myelogenous leukemic cells. Importantly, in these cells, SOS1 is required for BCR-ABL-mediated activation of RAC, cell proliferation and transformation in vitro and in a xenograft mouse model. Finally, genetic removal of Sos1 in the bone marrow-derived cells (BMDCs) from Sos1 fl/fl mice and infected with BCR-ABL causes a significant delay in the onset of leukemogenesis once BMDCs are injected into recipient, lethally irradiated mice. Thus, SOS1 is required for full transformation and critically contribute to the leukemogenic potential of BCR-ABL.-
dc.description.sponsorshipThis work has been supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC 10168 and 18621), the Italian Ministries of Education- University-Research (MIUR-PRIN-2009X23L78), the International Association For Cancer Research (AICR-09-0582 and 14-0335), the CARIPLO Foundation (2010-0737) and the European Research Council (Advanced-ERC268836). ALI was supported by a Grant from der German Jose Carreras Stiftung (DJCLS R14/22) and a Grant from the Government Baden-Württemberg (MWK). CM was supported form a AECC fellowship, Spain.-
dc.publisherNature Publishing Group-
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/268836-
dc.relation.isversionofPublisher's version-
dc.rightsopenAccess-
dc.titlePhosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis-
dc.typeartículo-
dc.identifier.doi10.1038/leu.2017.267-
dc.relation.publisherversionhttps://doi.org/10.1038/leu.2017.267-
dc.date.updated2018-09-03T11:47:16Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
dc.rights.licensehttp://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.contributor.funderAsociación Española Contra el Cáncer-
dc.contributor.funderMinistry of Science, Research and Art Baden-Württemberg-
dc.contributor.funderEuropean Commission-
dc.contributor.funderEuropean Research Council-
dc.contributor.funderJosep Carreras Leukemia Foundation-
dc.contributor.funderAssociazione Italiana per la Ricerca sul Cancro-
dc.contributor.funderFondazione Cariplo-
dc.contributor.funderAssociation for International Cancer Research-
dc.contributor.funderMinistero dell'Istruzione, dell'Università e della Ricerca-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/100004435es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003407es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100002803es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100005010es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003542es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100005677es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000781es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
dc.identifier.pmid28819285-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextopen-
item.openairetypeartículo-
item.fulltextWith Fulltext-
Aparece en las colecciones: (IBMCC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
phospleuke.pdf820,01 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

14
checked on 26-abr-2024

SCOPUSTM   
Citations

23
checked on 02-may-2024

WEB OF SCIENCETM
Citations

22
checked on 27-feb-2024

Page view(s)

338
checked on 03-may-2024

Download(s)

204
checked on 03-may-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons